Delanix 30 mg (Capsule (Enteric Coated))
Unit Price: ৳ 10.00 (5 x 10: ৳ 500.00)
Strip Price: ৳ 100.00
Medicine Details
Category | Details |
---|---|
Generic | Dexlansoprazole |
Company | Incepta pharmaceuticals ltd |
Also available as |
Title and Categories
- Delanix Dexlansoprazole Delayed-Release Capsule
- Medicine
- Gastrointestinal
- Pharmaceutical
Dimensions
- Single capsule size: standard pharmaceutical size
Color Options
- Capsule color: may vary based on pharmaceutical manufacturer
Functions
- Healing of Erosive Esophagitis
- Maintenance of Healed Erosive Esophagitis
- Relief of Heartburn
- Treatment of Symptomatic Non-Erosive Gastroesophageal Reflux Disease (GERD)
Materials
- Active ingredient: Dexlansoprazole
- Formulation: Dual Delayed Release (DDR) capsule
Technical Specifications
- Proton Pump Inhibitor (PPI)
- Specific inhibition of (H+/K+)-ATPase in the gastric parietal cell
- Dual delayed release formulation with two distinct peaks in plasma concentration-time profile
- Metabolized in the liver and excreted in urine
Usability Features
- Can be taken without regard to food
- Capsules can be administered by sprinkling intact granules on a tablespoon and swallowing immediately
- No dose adjustment for elderly patients
- No dose adjustment for patients with renal impairment
- Consideration of maximum daily dose for patients with moderate hepatic impairment
Dosage Recommendations
- 30 mg Once daily for Maintenance of Healed Erosive Esophagitis and relief of heartburn
- 30 mg Once daily for Symptomatic Non-Erosive GERD for 4 weeks
- 60 mg Once daily for Healing of Erosive Esophagitis for up to 8 weeks
- 30 mg tablet Once daily for Maintenance of Healed erosive esophagitis and relief of heartburn for 6 months in adults and 16 weeks in patients 12 to 17 years of age
- 30 mg tablet Once daily for Symptomatic Non-Erosive GERD for 4 weeks
Interaction
- May interact with Atazanavir, Warfarin, Tacrolimus, Clopidogrel & Methotrexate
Contraindications
- Contraindicated in patients with known hypersensitivity to any component of the formulation
Side Effects
- Common side effects include diarrhea, abdominal pain, nausea, vomiting & flatulence
Pregnancy & Lactation
- Pregnancy Category B
- No adequate and well-controlled studies with Dexlansoprazole in pregnant women
- No adequate and well-controlled studies with Dexlansoprazole in Lactating mother
Precautions & Warnings
- Gastric Malignancy
- Clostridium difficile Associated Diarrhea
- Bone fracture
- Hypomagnesemia
- Concomitant use of Delanix with Methotrexate
Special Populations
- Safety and effectiveness in children below 12 years age have not been established
- No dose adjustment necessary for elderly patients
- No dose adjustment for patients with renal impairment
- No dose adjustment necessary for patients with mild hepatic impairment
- Consider a maximum daily dose of 30 mg for patients with moderate hepatic impairment
Overdose Effects
- No reports of significant overdose of Delanix
- Multiple doses of Delanix 120 mg and a single dose of Delanix 300 mg did not result in severe adverse events or death
Therapeutic Class
- Proton Pump Inhibitor
Storage Conditions
- Store below 30°C, in a dry place and protected from light
- Keep all medicines out of reach of children
Related Brands
- Dexilend 30 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Dexilend 60 mg (Capsule (Enteric Coated)) - ziska-pharmaceuticals-ltd
- Dexlan 30 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Dexlan 60 mg (Capsule (Enteric Coated)) - ibn-sina-pharmaceuticals-ltd
- Desopra 30 mg (Capsule (Enteric Coated)) - alco-pharma-ltd